General Information
Otsuka MDD 331-13-001
A phase 3b, Multicenter, Open-label Trial to Evaluate the Efficacy, Safety and Subject Satisfaction of Brexipiprazole as Adjunctive Therapy in the treatment of Adults with Major Depressive Disorder and an inadequate Response to Previous Adjunctive Therapy.
| Protocol | 331-13-001 |
|---|---|
| Identifier | |
| UID | 96444c2e-9d6f-4488-a361-cff61b40cd73 |
| Status | Cancelled |
| Phase | 3b |
| Category | Major Depressive Disorder |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2013-09-10 11:28 |
| Last Updated | 2013-09-10 11:28 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | - | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Otsuka Pharmaceuticals |
|---|---|
| Division | Otsuka Pharmaceuticals |
| Team | Otsuka Pharmaceuticals |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Inc Research, LLC |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Yellow |
| Currency | - |
